Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Niemann-Pick Type C disease-related technology available for licensing from NIH

Oct. 30, 1997

No Comments

Beta3-adrenoceptor agonists reported by Asahi Chemical

Oct. 30, 1997

No Comments

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

No Comments

New ACAT inhibitors discovered at Mitsubishi Chemical

Oct. 29, 1997

No Comments

FDA clears generic estradiol product

Oct. 29, 1997

No Comments

Shaman issued U.S. patent for antidiabetic compounds

Oct. 28, 1997

No Comments

Watson acquires Searle contraceptive products

Oct. 27, 1997

No Comments

New antidiabetic agents from Boehringer Mannheim

Oct. 24, 1997

No Comments

Major advance in thalassemia research reported

Oct. 24, 1997

No Comments

Lower dose version of Caverject introduced

Oct. 23, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Niemann-Pick Type C disease-related technology available for licensing from NIH

Beta3-adrenoceptor agonists reported by Asahi Chemical

Pravachol now available in Canada for preventing a first heart attack

New ACAT inhibitors discovered at Mitsubishi Chemical

FDA clears generic estradiol product

Shaman issued U.S. patent for antidiabetic compounds

Watson acquires Searle contraceptive products

New antidiabetic agents from Boehringer Mannheim

Major advance in thalassemia research reported

Lower dose version of Caverject introduced

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS